rs6512305

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001386971.1(LKAAEAR1):​c.-15C>T variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.489 in 151,956 control chromosomes in the GnomAD database, including 18,365 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.49 ( 18357 hom., cov: 32)
Exomes 𝑓: 0.47 ( 8 hom. )

Consequence

LKAAEAR1
NM_001386971.1 5_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.17

Publications

8 publications found
Variant links:
Genes affected
OPRL1 (HGNC:8155): (opioid related nociceptin receptor 1) The protein encoded by this gene is a member of the 7 transmembrane-spanning G protein-coupled receptor family, and functions as a receptor for the endogenous, opioid-related neuropeptide, nociceptin/orphanin FQ. This receptor-ligand system modulates a variety of biological functions and neurobehavior, including stress responses and anxiety behavior, learning and memory, locomotor activity, and inflammatory and immune responses. A promoter region between this gene and the 5'-adjacent RGS19 (regulator of G-protein signaling 19) gene on the opposite strand functions bi-directionally as a core-promoter for both genes, suggesting co-operative transcriptional regulation of these two functionally related genes. Alternatively spliced transcript variants have been described for this gene. A recent study provided evidence for translational readthrough in this gene, and expression of an additional C-terminally extended isoform via the use of an alternative in-frame translation termination codon. [provided by RefSeq, Dec 2017]
LKAAEAR1 (HGNC:33718): (LKAAEAR motif containing 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.573 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001386971.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
OPRL1
NM_182647.4
MANE Select
c.-185+4565G>A
intron
N/ANP_872588.1P41146-1
LKAAEAR1
NM_001386971.1
c.-15C>T
5_prime_UTR
Exon 1 of 4NP_001373900.1Q8TD35-1
OPRL1
NM_001318853.2
c.-185+4565G>A
intron
N/ANP_001305782.1A0A5F9ZI64

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
OPRL1
ENST00000336866.7
TSL:5 MANE Select
c.-185+4565G>A
intron
N/AENSP00000336843.2P41146-1
OPRL1
ENST00000355631.8
TSL:1
c.-34+4565G>A
intron
N/AENSP00000347848.4P41146-1
OPRL1
ENST00000879250.1
c.-234G>A
5_prime_UTR
Exon 1 of 5ENSP00000549309.1

Frequencies

GnomAD3 genomes
AF:
0.489
AC:
74262
AN:
151772
Hom.:
18357
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.461
Gnomad AMI
AF:
0.526
Gnomad AMR
AF:
0.561
Gnomad ASJ
AF:
0.485
Gnomad EAS
AF:
0.591
Gnomad SAS
AF:
0.408
Gnomad FIN
AF:
0.577
Gnomad MID
AF:
0.548
Gnomad NFE
AF:
0.474
Gnomad OTH
AF:
0.488
GnomAD4 exome
AF:
0.471
AC:
32
AN:
68
Hom.:
8
AF XY:
0.477
AC XY:
21
AN XY:
44
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AF:
0.00
AC:
0
AN:
2
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
0.750
AC:
9
AN:
12
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.386
AC:
17
AN:
44
Other (OTH)
AF:
0.600
AC:
6
AN:
10
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.489
AC:
74292
AN:
151888
Hom.:
18357
Cov.:
32
AF XY:
0.494
AC XY:
36709
AN XY:
74244
show subpopulations
African (AFR)
AF:
0.461
AC:
19084
AN:
41418
American (AMR)
AF:
0.560
AC:
8565
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.485
AC:
1681
AN:
3468
East Asian (EAS)
AF:
0.591
AC:
3035
AN:
5138
South Asian (SAS)
AF:
0.408
AC:
1968
AN:
4822
European-Finnish (FIN)
AF:
0.577
AC:
6093
AN:
10556
Middle Eastern (MID)
AF:
0.545
AC:
159
AN:
292
European-Non Finnish (NFE)
AF:
0.474
AC:
32195
AN:
67886
Other (OTH)
AF:
0.490
AC:
1033
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1971
3942
5913
7884
9855
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
670
1340
2010
2680
3350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.475
Hom.:
2191
Bravo
AF:
0.486
Asia WGS
AF:
0.501
AC:
1744
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.94
CADD
Benign
1.4
DANN
Benign
0.84
PhyloP100
-1.2
PromoterAI
-0.028
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6512305; hg19: chr20-62716270; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.